Postgraduate Program in Environment, Universidade Ceuma, São Luís, Brazil.
Postgraduate Program in Physical Therapy, Universidade Federal de São Carlos, São Carlos, Brazil.
Front Endocrinol (Lausanne). 2022 Apr 14;13:869921. doi: 10.3389/fendo.2022.869921. eCollection 2022.
Diabetes mellitus (DM) is a chronic metabolic disease characterized by high blood glucose levels, causing serious damage to the cardiovascular, respiratory, renal and other systems. The prevalence of type 2 diabetes mellitus (T2DM) was 6.28% in 2017, considering all age groups worldwide (prevalence rate of 6,059 cases per 100,000), and its global prevalence is projected to increase to 7,079 cases per 100,000 by 2030. Furthermore, these individuals are often affected by diabetic myopathy, which is the failure to preserve muscle mass and function in the course of DM. This happens in type 1 diabetes mellitus (T1DM) and T2DM. As skeletal muscle plays a key role in locomotion and glucose homeostasis, diabetic myopathy may contribute to additional complications of the disease. In addition, chronic hyperglycemia is associated with lung functional changes seen in patients with DM, such as reduced lung volumes and compliance, inspiratory muscle strength, and lung elastic recoil. Thus, the weakness of the inspiratory muscles, a consequence of diabetic myopathy, can influence exercise tolerance. Thus, moderate strength training in T2DM can contribute to the gain of peripheral muscle strength. Although the literature is robust on the loss of mass and consequent muscle weakness in diabetic myopathy, triggering pathophysiological factors, the impact on functional capacity, as well as the prescription of physical exercise for this condition deserves to be further explored. This review aims to explore the consequences of diabetic myopathy and its implication in rehabilitation from prescription to safety in the practice of physical exercises for these individuals.
糖尿病(DM)是一种慢性代谢性疾病,其特征是血糖水平升高,导致心血管、呼吸、肾脏等系统受到严重损害。2017 年,全球所有年龄段的 2 型糖尿病(T2DM)患病率为 6.28%(每 10 万人中有 6059 例患病率),预计到 2030 年将增加到每 10 万人中有 7079 例。此外,这些患者通常还患有糖尿病性肌病,即在糖尿病过程中无法保持肌肉质量和功能。1 型糖尿病(T1DM)和 T2DM 中都会出现这种情况。由于骨骼肌在运动和葡萄糖稳态中起着关键作用,因此糖尿病性肌病可能会导致疾病的其他并发症。此外,慢性高血糖与糖尿病患者的肺功能变化有关,如肺容积和顺应性降低、吸气肌力量和肺弹性回缩力降低。因此,糖尿病性肌病导致的吸气肌无力会影响运动耐量。因此,T2DM 中的适度力量训练可以有助于外周肌肉力量的增加。尽管文献中关于糖尿病性肌病导致的质量损失和随之而来的肌肉无力有大量报道,但触发病理生理因素、对功能能力的影响以及针对这种情况的体育锻炼处方仍有待进一步探索。本综述旨在探讨糖尿病性肌病的后果及其对这些患者进行体育锻炼时的康复治疗从处方到安全性的影响。